Maxim Group Upgrades Co-Diagnostics (CODX) to Buy
Tweet
Share
E-mailGet Alerts CODX Hot Sheet
Price: $1.40 -6.04%
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
1 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Maxim Group analyst Jason McCarthy upgraded Co-Diagnostics (NASDAQ: CODX) from Hold to Buy.
For an analyst ratings summary and ratings history on Co-Diagnostics click here. For more ratings news on Co-Diagnostics click here.
Shares of Co-Diagnostics closed at $18.85 yesterday.
You May Also Be Interested In
- Co-Diagnostics (CODX) Tops Q2 EPS by $1.54, Beats on Revenue
- Desjardins Upgrades PRO REIT (PRV-U:CN) to Buy
- Freedom Broker Upgrades Serve Robotics (SERV) to Buy
Create E-mail Alert Related Categories
UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
